At Certara, we merge scientific insight with real-world data to create market access strategies that prioritize patient outcomes while maximizing your market potential.
Real-world Evidence and Market Access Services
Transform potential to commercial success
Data-driven, patient centric, and market sensitive.
70
Market Access and HEOR professionals
25
years' experience on average in providing HEOR and market access solutions
1
integrated offering to define, capture and communicate value
With 25+ years of HEOR consulting expertise, we offer HTA health economic analyses, clinical trial analytics for HTA applications, epidemiology
Discover Certara's comprehensive Real-World Evidence Services. We provide innovative RWE solutions for pharma, empowering regulatory, market access, and clinical strategies.
Explore Certara's Value and Access services, a combination of proven payer strategies and scientific excellence to optimize market access.
Certara’s Market Access & Commercial solutions provide strategic insights and tools to optimize pricing, reimbursement, and market entry strategies.
Services offered by Certara global market access experts to navigate the new EU HTA Regulation and prepare timely and high
Certara’s US Managed Markets solutions support scientific value story development, payer engagement and multi-faceted go-to-market strategies.
Explore our payer engagement strategies. Access expertise in HTA, clinical assessments & decision-making processes to optimize market access.
Real-world evidence for real impact
Regulatory approval isn’t enough. It doesn’t guarantee market access and reimbursement. Certara continually curates real-world evidence to ensure that your expectations and negotiations are credible to payers, patients and investors. This contributes to incentives and arguments for further drug development.
Resources for market access success
View allStart your market access journey today
Ask how Certara can help your organization achieve commercial success while improving patient outcomes globally.
A strategic partner that gives you all the tools to communicate value at each step
Data-driven decisions for your most innovative products
Leverage the latest analytical and modeling methodologies to demonstrate value
Send an Inquiry
Current thinking in market access
Rare Oncology Product Launch Playbook: Universal Strategies for Success in the U.S. and Europe
In this white paper, Certara’s Global Market Access experts highlight the most consequential differences to consider when preparing to launch a rare oncology product in major markets
Learn more
Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement
Research details the Inflation Reduction Act’s small but measurable impact and offers insights in several key areas.
Learn more
Management of Vulnerable Patients Hospitalized for COVID-19 with Remdesivir
A retrospective comparative effectiveness study of mortality in US hospitals
Learn more